Global Bevacizumab Injection Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bevacizumab Injection Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bevacizumab Injection by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bevacizumab Injection by Country/Region, 2017, 2022 & 2028

2.2 Bevacizumab Injection Segment by Type

2.2.1 100mg

2.2.2 400mg

2.3 Bevacizumab Injection Sales by Type

2.3.1 Global Bevacizumab Injection Sales Market Share by Type (2017-2022)

2.3.2 Global Bevacizumab Injection Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bevacizumab Injection Sale Price by Type (2017-2022)

2.4 Bevacizumab Injection Segment by Application

2.4.1 Age-related macular degeneration (AMD)

2.4.2 Ovarian Cancer

2.4.3 Others

2.5 Bevacizumab Injection Sales by Application

2.5.1 Global Bevacizumab Injection Sale Market Share by Application (2017-2022)

2.5.2 Global Bevacizumab Injection Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bevacizumab Injection Sale Price by Application (2017-2022)

3 Global Bevacizumab Injection by Company

3.1 Global Bevacizumab Injection Breakdown Data by Company

3.1.1 Global Bevacizumab Injection Annual Sales by Company (2020-2022)

3.1.2 Global Bevacizumab Injection Sales Market Share by Company (2020-2022)

3.2 Global Bevacizumab Injection Annual Revenue by Company (2020-2022)

3.2.1 Global Bevacizumab Injection Revenue by Company (2020-2022)

3.2.2 Global Bevacizumab Injection Revenue Market Share by Company (2020-2022)

3.3 Global Bevacizumab Injection Sale Price by Company

3.4 Key Manufacturers Bevacizumab Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bevacizumab Injection Product Location Distribution

3.4.2 Players Bevacizumab Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bevacizumab Injection by Geographic Region

4.1 World Historic Bevacizumab Injection Market Size by Geographic Region (2017-2022)

4.1.1 Global Bevacizumab Injection Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bevacizumab Injection Annual Revenue by Geographic Region

4.2 World Historic Bevacizumab Injection Market Size by Country/Region (2017-2022)

4.2.1 Global Bevacizumab Injection Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bevacizumab Injection Annual Revenue by Country/Region

4.3 Americas Bevacizumab Injection Sales Growth

4.4 APAC Bevacizumab Injection Sales Growth

4.5 Europe Bevacizumab Injection Sales Growth

4.6 Middle East & Africa Bevacizumab Injection Sales Growth

5 Americas

5.1 Americas Bevacizumab Injection Sales by Country

5.1.1 Americas Bevacizumab Injection Sales by Country (2017-2022)

5.1.2 Americas Bevacizumab Injection Revenue by Country (2017-2022)

5.2 Americas Bevacizumab Injection Sales by Type

5.3 Americas Bevacizumab Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bevacizumab Injection Sales by Region

6.1.1 APAC Bevacizumab Injection Sales by Region (2017-2022)

6.1.2 APAC Bevacizumab Injection Revenue by Region (2017-2022)

6.2 APAC Bevacizumab Injection Sales by Type

6.3 APAC Bevacizumab Injection Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bevacizumab Injection by Country

7.1.1 Europe Bevacizumab Injection Sales by Country (2017-2022)

7.1.2 Europe Bevacizumab Injection Revenue by Country (2017-2022)

7.2 Europe Bevacizumab Injection Sales by Type

7.3 Europe Bevacizumab Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bevacizumab Injection by Country

8.1.1 Middle East & Africa Bevacizumab Injection Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bevacizumab Injection Revenue by Country (2017-2022)

8.2 Middle East & Africa Bevacizumab Injection Sales by Type

8.3 Middle East & Africa Bevacizumab Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bevacizumab Injection

10.3 Manufacturing Process Analysis of Bevacizumab Injection

10.4 Industry Chain Structure of Bevacizumab Injection

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bevacizumab Injection Distributors

11.3 Bevacizumab Injection Customer

12 World Forecast Review for Bevacizumab Injection by Geographic Region

12.1 Global Bevacizumab Injection Market Size Forecast by Region

12.1.1 Global Bevacizumab Injection Forecast by Region (2023-2028)

12.1.2 Global Bevacizumab Injection Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bevacizumab Injection Forecast by Type

12.7 Global Bevacizumab Injection Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Bevacizumab Injection Product Offered

13.1.3 Pfizer Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Bevacizumab Injection Product Offered

13.2.3 Roche Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 Eli Lilly

13.3.1 Eli Lilly Company Information

13.3.2 Eli Lilly Bevacizumab Injection Product Offered

13.3.3 Eli Lilly Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly Main Business Overview

13.3.5 Eli Lilly Latest Developments

13.4 Genentech

13.4.1 Genentech Company Information

13.4.2 Genentech Bevacizumab Injection Product Offered

13.4.3 Genentech Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Genentech Main Business Overview

13.4.5 Genentech Latest Developments

13.5 Bayer

13.5.1 Bayer Company Information

13.5.2 Bayer Bevacizumab Injection Product Offered

13.5.3 Bayer Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bayer Main Business Overview

13.5.5 Bayer Latest Developments

13.6 Amgen

13.6.1 Amgen Company Information

13.6.2 Amgen Bevacizumab Injection Product Offered

13.6.3 Amgen Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Amgen Main Business Overview

13.6.5 Amgen Latest Developments

13.7 Samsung Bioepis

13.7.1 Samsung Bioepis Company Information

13.7.2 Samsung Bioepis Bevacizumab Injection Product Offered

13.7.3 Samsung Bioepis Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Samsung Bioepis Main Business Overview

13.7.5 Samsung Bioepis Latest Developments

13.8 Centus

13.8.1 Centus Company Information

13.8.2 Centus Bevacizumab Injection Product Offered

13.8.3 Centus Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Centus Main Business Overview

13.8.5 Centus Latest Developments

13.9 Cadila Pharmaceuticals

13.9.1 Cadila Pharmaceuticals Company Information

13.9.2 Cadila Pharmaceuticals Bevacizumab Injection Product Offered

13.9.3 Cadila Pharmaceuticals Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Cadila Pharmaceuticals Main Business Overview

13.9.5 Cadila Pharmaceuticals Latest Developments

13.10 Dr Reddy's

13.10.1 Dr Reddy's Company Information

13.10.2 Dr Reddy's Bevacizumab Injection Product Offered

13.10.3 Dr Reddy's Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Dr Reddy's Main Business Overview

13.10.5 Dr Reddy's Latest Developments

13.11 Mylan

13.11.1 Mylan Company Information

13.11.2 Mylan Bevacizumab Injection Product Offered

13.11.3 Mylan Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Mylan Main Business Overview

13.11.5 Mylan Latest Developments

13.12 Hetero Group

13.12.1 Hetero Group Company Information

13.12.2 Hetero Group Bevacizumab Injection Product Offered

13.12.3 Hetero Group Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Hetero Group Main Business Overview

13.12.5 Hetero Group Latest Developments

13.13 Biocon

13.13.1 Biocon Company Information

13.13.2 Biocon Bevacizumab Injection Product Offered

13.13.3 Biocon Bevacizumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Biocon Main Business Overview

13.13.5 Biocon Latest Developments

14 Research Findings and Conclusion

Table 1. Bevacizumab Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bevacizumab Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 100mg

Table 4. Major Players of 400mg

Table 5. Global Bevacizumab Injection Sales by Type (2017-2022) & (K Doses)

Table 6. Global Bevacizumab Injection Sales Market Share by Type (2017-2022)

Table 7. Global Bevacizumab Injection Revenue by Type (2017-2022) & ($ million)

Table 8. Global Bevacizumab Injection Revenue Market Share by Type (2017-2022)

Table 9. Global Bevacizumab Injection Sale Price by Type (2017-2022) & (US$/Dose)

Table 10. Global Bevacizumab Injection Sales by Application (2017-2022) & (K Doses)

Table 11. Global Bevacizumab Injection Sales Market Share by Application (2017-2022)

Table 12. Global Bevacizumab Injection Revenue by Application (2017-2022)

Table 13. Global Bevacizumab Injection Revenue Market Share by Application (2017-2022)

Table 14. Global Bevacizumab Injection Sale Price by Application (2017-2022) & (US$/Dose)

Table 15. Global Bevacizumab Injection Sales by Company (2020-2022) & (K Doses)

Table 16. Global Bevacizumab Injection Sales Market Share by Company (2020-2022)

Table 17. Global Bevacizumab Injection Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Bevacizumab Injection Revenue Market Share by Company (2020-2022)

Table 19. Global Bevacizumab Injection Sale Price by Company (2020-2022) & (US$/Dose)

Table 20. Key Manufacturers Bevacizumab Injection Producing Area Distribution and Sales Area

Table 21. Players Bevacizumab Injection Products Offered

Table 22. Bevacizumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Bevacizumab Injection Sales by Geographic Region (2017-2022) & (K Doses)

Table 26. Global Bevacizumab Injection Sales Market Share Geographic Region (2017-2022)

Table 27. Global Bevacizumab Injection Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Bevacizumab Injection Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Bevacizumab Injection Sales by Country/Region (2017-2022) & (K Doses)

Table 30. Global Bevacizumab Injection Sales Market Share by Country/Region (2017-2022)

Table 31. Global Bevacizumab Injection Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Bevacizumab Injection Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Bevacizumab Injection Sales by Country (2017-2022) & (K Doses)

Table 34. Americas Bevacizumab Injection Sales Market Share by Country (2017-2022)

Table 35. Americas Bevacizumab Injection Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Bevacizumab Injection Revenue Market Share by Country (2017-2022)

Table 37. Americas Bevacizumab Injection Sales by Type (2017-2022) & (K Doses)

Table 38. Americas Bevacizumab Injection Sales Market Share by Type (2017-2022)

Table 39. Americas Bevacizumab Injection Sales by Application (2017-2022) & (K Doses)

Table 40. Americas Bevacizumab Injection Sales Market Share by Application (2017-2022)

Table 41. APAC Bevacizumab Injection Sales by Region (2017-2022) & (K Doses)

Table 42. APAC Bevacizumab Injection Sales Market Share by Region (2017-2022)

Table 43. APAC Bevacizumab Injection Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Bevacizumab Injection Revenue Market Share by Region (2017-2022)

Table 45. APAC Bevacizumab Injection Sales by Type (2017-2022) & (K Doses)

Table 46. APAC Bevacizumab Injection Sales Market Share by Type (2017-2022)

Table 47. APAC Bevacizumab Injection Sales by Application (2017-2022) & (K Doses)

Table 48. APAC Bevacizumab Injection Sales Market Share by Application (2017-2022)

Table 49. Europe Bevacizumab Injection Sales by Country (2017-2022) & (K Doses)

Table 50. Europe Bevacizumab Injection Sales Market Share by Country (2017-2022)

Table 51. Europe Bevacizumab Injection Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Bevacizumab Injection Revenue Market Share by Country (2017-2022)

Table 53. Europe Bevacizumab Injection Sales by Type (2017-2022) & (K Doses)

Table 54. Europe Bevacizumab Injection Sales Market Share by Type (2017-2022)

Table 55. Europe Bevacizumab Injection Sales by Application (2017-2022) & (K Doses)

Table 56. Europe Bevacizumab Injection Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Bevacizumab Injection Sales by Country (2017-2022) & (K Doses)

Table 58. Middle East & Africa Bevacizumab Injection Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Bevacizumab Injection Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Bevacizumab Injection Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Bevacizumab Injection Sales by Type (2017-2022) & (K Doses)

Table 62. Middle East & Africa Bevacizumab Injection Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Bevacizumab Injection Sales by Application (2017-2022) & (K Doses)

Table 64. Middle East & Africa Bevacizumab Injection Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Bevacizumab Injection

Table 66. Key Market Challenges & Risks of Bevacizumab Injection

Table 67. Key Industry Trends of Bevacizumab Injection

Table 68. Bevacizumab Injection Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Bevacizumab Injection Distributors List

Table 71. Bevacizumab Injection Customer List

Table 72. Global Bevacizumab Injection Sales Forecast by Region (2023-2028) & (K Doses)

Table 73. Global Bevacizumab Injection Sales Market Forecast by Region

Table 74. Global Bevacizumab Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Bevacizumab Injection Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Bevacizumab Injection Sales Forecast by Country (2023-2028) & (K Doses)

Table 77. Americas Bevacizumab Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Bevacizumab Injection Sales Forecast by Region (2023-2028) & (K Doses)

Table 79. APAC Bevacizumab Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Bevacizumab Injection Sales Forecast by Country (2023-2028) & (K Doses)

Table 81. Europe Bevacizumab Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Bevacizumab Injection Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Middle East & Africa Bevacizumab Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Bevacizumab Injection Sales Forecast by Type (2023-2028) & (K Doses)

Table 85. Global Bevacizumab Injection Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Bevacizumab Injection Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Bevacizumab Injection Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Bevacizumab Injection Sales Forecast by Application (2023-2028) & (K Doses)

Table 89. Global Bevacizumab Injection Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Bevacizumab Injection Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Bevacizumab Injection Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pfizer Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 93. Pfizer Bevacizumab Injection Product Offered

Table 94. Pfizer Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 95. Pfizer Main Business

Table 96. Pfizer Latest Developments

Table 97. Roche Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 98. Roche Bevacizumab Injection Product Offered

Table 99. Roche Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 100. Roche Main Business

Table 101. Roche Latest Developments

Table 102. Eli Lilly Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 103. Eli Lilly Bevacizumab Injection Product Offered

Table 104. Eli Lilly Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 105. Eli Lilly Main Business

Table 106. Eli Lilly Latest Developments

Table 107. Genentech Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 108. Genentech Bevacizumab Injection Product Offered

Table 109. Genentech Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 110. Genentech Main Business

Table 111. Genentech Latest Developments

Table 112. Bayer Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 113. Bayer Bevacizumab Injection Product Offered

Table 114. Bayer Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 115. Bayer Main Business

Table 116. Bayer Latest Developments

Table 117. Amgen Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 118. Amgen Bevacizumab Injection Product Offered

Table 119. Amgen Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 120. Amgen Main Business

Table 121. Amgen Latest Developments

Table 122. Samsung Bioepis Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 123. Samsung Bioepis Bevacizumab Injection Product Offered

Table 124. Samsung Bioepis Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 125. Samsung Bioepis Main Business

Table 126. Samsung Bioepis Latest Developments

Table 127. Centus Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 128. Centus Bevacizumab Injection Product Offered

Table 129. Centus Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 130. Centus Main Business

Table 131. Centus Latest Developments

Table 132. Cadila Pharmaceuticals Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 133. Cadila Pharmaceuticals Bevacizumab Injection Product Offered

Table 134. Cadila Pharmaceuticals Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 135. Cadila Pharmaceuticals Main Business

Table 136. Cadila Pharmaceuticals Latest Developments

Table 137. Dr Reddy's Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 138. Dr Reddy's Bevacizumab Injection Product Offered

Table 139. Dr Reddy's Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 140. Dr Reddy's Main Business

Table 141. Dr Reddy's Latest Developments

Table 142. Mylan Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 143. Mylan Bevacizumab Injection Product Offered

Table 144. Mylan Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 145. Mylan Main Business

Table 146. Mylan Latest Developments

Table 147. Hetero Group Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 148. Hetero Group Bevacizumab Injection Product Offered

Table 149. Hetero Group Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 150. Hetero Group Main Business

Table 151. Hetero Group Latest Developments

Table 152. Biocon Basic Information, Bevacizumab Injection Manufacturing Base, Sales Area and Its Competitors

Table 153. Biocon Bevacizumab Injection Product Offered

Table 154. Biocon Bevacizumab Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 155. Biocon Main Business

Table 156. Biocon Latest Developments

List of Figures

Figure 1. Picture of Bevacizumab Injection

Figure 2. Bevacizumab Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bevacizumab Injection Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Bevacizumab Injection Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bevacizumab Injection Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 100mg

Figure 10. Product Picture of 400mg

Figure 11. Global Bevacizumab Injection Sales Market Share by Type in 2021

Figure 12. Global Bevacizumab Injection Revenue Market Share by Type (2017-2022)

Figure 13. Bevacizumab Injection Consumed in Age-related macular degeneration (AMD)

Figure 14. Global Bevacizumab Injection Market: Age-related macular degeneration (AMD) (2017-2022) & (K Doses)

Figure 15. Bevacizumab Injection Consumed in Ovarian Cancer

Figure 16. Global Bevacizumab Injection Market: Ovarian Cancer (2017-2022) & (K Doses)

Figure 17. Bevacizumab Injection Consumed in Others

Figure 18. Global Bevacizumab Injection Market: Others (2017-2022) & (K Doses)

Figure 19. Global Bevacizumab Injection Sales Market Share by Application (2017-2022)

Figure 20. Global Bevacizumab Injection Revenue Market Share by Application in 2021

Figure 21. Bevacizumab Injection Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Bevacizumab Injection Revenue Market Share by Company in 2021

Figure 23. Global Bevacizumab Injection Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Bevacizumab Injection Revenue Market Share by Geographic Region in 2021

Figure 25. Global Bevacizumab Injection Sales Market Share by Region (2017-2022)

Figure 26. Global Bevacizumab Injection Revenue Market Share by Country/Region in 2021

Figure 27. Americas Bevacizumab Injection Sales 2017-2022 (K Doses)

Figure 28. Americas Bevacizumab Injection Revenue 2017-2022 ($ Millions)

Figure 29. APAC Bevacizumab Injection Sales 2017-2022 (K Doses)

Figure 30. APAC Bevacizumab Injection Revenue 2017-2022 ($ Millions)

Figure 31. Europe Bevacizumab Injection Sales 2017-2022 (K Doses)

Figure 32. Europe Bevacizumab Injection Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Bevacizumab Injection Sales 2017-2022 (K Doses)

Figure 34. Middle East & Africa Bevacizumab Injection Revenue 2017-2022 ($ Millions)

Figure 35. Americas Bevacizumab Injection Sales Market Share by Country in 2021

Figure 36. Americas Bevacizumab Injection Revenue Market Share by Country in 2021

Figure 37. United States Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Bevacizumab Injection Sales Market Share by Region in 2021

Figure 42. APAC Bevacizumab Injection Revenue Market Share by Regions in 2021

Figure 43. China Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Bevacizumab Injection Sales Market Share by Country in 2021

Figure 50. Europe Bevacizumab Injection Revenue Market Share by Country in 2021

Figure 51. Germany Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Bevacizumab Injection Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Bevacizumab Injection Revenue Market Share by Country in 2021

Figure 58. Egypt Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Bevacizumab Injection Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Bevacizumab Injection in 2021

Figure 64. Manufacturing Process Analysis of Bevacizumab Injection

Figure 65. Industry Chain Structure of Bevacizumab Injection

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles